does premera blue cross cover tirzepatide for diabetic patients Blue Shield Mounjaro? does premera blue cross cover

Filed by Novo Nordisk A/S

Direct anti-inflammatory properties of GLP-1 receptor activation combine with the indirect inflammation reduction from losing visceral fat

The SELECT trial recently showed semaglutide reduces MACE by 20 percent even in nondiabetic patients with cardiovascular disease

There are many potential/partial explanations for this difference: Tirzepatide is a dual agonist (for GIP/GLP-1), making it an arguably more structurally complex molecule and less tenable for recombinant expression (though both are linear peptides with a side chain)

Blood was collected via a jugular vein catheter at 5, 15 and 30 min and 1, 2, 4, 8 and 24 h after intravenous dosing, or for intraduodenal groups at 15 min predose and 0.5, 1, 2, 4, 8, 24 and 48 h postdose